Pharmacokinetic/Pharmacodynamic Relationship of Gabapentin in a CFA-induced Inflammatory Hyperalgesia Rat Model
Autor: | Rada M. Savic, Gordon Munro, Mads Kreilgaard, René Holm, Malte Selch Larsen, Ron J. Keizer, Arne Mørk |
---|---|
Rok vydání: | 2016 |
Předmět: |
Male
Cyclohexanecarboxylic Acids Gabapentin Population Biological Availability Pharmaceutical Science Pharmacology Models Biological 030226 pharmacology & pharmacy Intestinal absorption Rats Sprague-Dawley 03 medical and health sciences 0302 clinical medicine Pharmacokinetics Extracellular fluid medicine Animals Computer Simulation Pharmacology (medical) Amines education gamma-Aminobutyric Acid Analgesics education.field_of_study Chemistry Organic Chemistry Brain Rats Bioavailability Hyperalgesia Pharmacodynamics Molecular Medicine medicine.symptom 030217 neurology & neurosurgery Biotechnology medicine.drug |
Zdroj: | Pharmaceutical Research. 33:1133-1143 |
ISSN: | 1573-904X 0724-8741 |
DOI: | 10.1007/s11095-016-1859-7 |
Popis: | Gabapentin displays non-linear drug disposition, which complicates dosing for optimal therapeutic effect. Thus, the current study was performed to elucidate the pharmacokinetic/pharmacodynamic (PKPD) relationship of gabapentin’s effect on mechanical hypersensitivity in a rat model of CFA-induced inflammatory hyperalgesia. A semi-mechanistic population-based PKPD model was developed using nonlinear mixed-effects modelling, based on gabapentin plasma and brain extracellular fluid (ECF) time-concentration data and measurements of CFA-evoked mechanical hyperalgesia following administration of a range of gabapentin doses (oral and intravenous). The plasma/brain ECF concentration-time profiles of gabapentin were adequately described with a two-compartment plasma model with saturable intestinal absorption rate (K m = 44.1 mg/kg, V max = 41.9 mg/h∙kg) and dose-dependent oral bioavailability linked to brain ECF concentration through a transit compartment. Brain ECF concentration was directly linked to a sigmoid E max function describing reversal of hyperalgesia (EC 50, plasma = 16.7 μg/mL, EC 50, brain = 3.3 μg/mL). The proposed semi-mechanistic population-based PKPD model provides further knowledge into the understanding of gabapentin’s non-linear pharmacokinetics and the link between plasma/brain disposition and anti-hyperalgesic effects. The model suggests that intestinal absorption is the primary source of non-linearity and that the investigated rat model provides reasonable predictions of clinically effective plasma concentrations for gabapentin. |
Databáze: | OpenAIRE |
Externí odkaz: |